The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cord Blood Stem Cells Market Research Report 2025
Synopsis
The global Cord Blood Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cord Blood Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Stem Cells.
Report Scope
The Cord Blood Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cord Blood Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cord Blood Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Segment by Type
Allogeneic Stem Cell
Autologous Stem Cell
Segment by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cord Blood Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cord Blood Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cord Blood Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Stem Cells.
Report Scope
The Cord Blood Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cord Blood Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cord Blood Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Segment by Type
Allogeneic Stem Cell
Autologous Stem Cell
Segment by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cord Blood Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cord Blood Stem Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic Stem Cell
1.2.3 Autologous Stem Cell
1.3 Market by Application
1.3.1 Global Cord Blood Stem Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Autoimmune Diseases
1.3.3 Immunodeficiencies
1.3.4 Malignancies,Caners
1.3.5 Solid Tumors
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cord Blood Stem Cells Market Perspective (2019-2030)
2.2 Cord Blood Stem Cells Growth Trends by Region
2.2.1 Global Cord Blood Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cord Blood Stem Cells Historic Market Size by Region (2019-2024)
2.2.3 Cord Blood Stem Cells Forecasted Market Size by Region (2025-2030)
2.3 Cord Blood Stem Cells Market Dynamics
2.3.1 Cord Blood Stem Cells Industry Trends
2.3.2 Cord Blood Stem Cells Market Drivers
2.3.3 Cord Blood Stem Cells Market Challenges
2.3.4 Cord Blood Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cord Blood Stem Cells Players by Revenue
3.1.1 Global Top Cord Blood Stem Cells Players by Revenue (2019-2024)
3.1.2 Global Cord Blood Stem Cells Revenue Market Share by Players (2019-2024)
3.2 Global Cord Blood Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cord Blood Stem Cells Revenue
3.4 Global Cord Blood Stem Cells Market Concentration Ratio
3.4.1 Global Cord Blood Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cord Blood Stem Cells Revenue in 2023
3.5 Cord Blood Stem Cells Key Players Head office and Area Served
3.6 Key Players Cord Blood Stem Cells Product Solution and Service
3.7 Date of Enter into Cord Blood Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cord Blood Stem Cells Breakdown Data by Type
4.1 Global Cord Blood Stem Cells Historic Market Size by Type (2019-2024)
4.2 Global Cord Blood Stem Cells Forecasted Market Size by Type (2025-2030)
5 Cord Blood Stem Cells Breakdown Data by Application
5.1 Global Cord Blood Stem Cells Historic Market Size by Application (2019-2024)
5.2 Global Cord Blood Stem Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cord Blood Stem Cells Market Size (2019-2030)
6.2 North America Cord Blood Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cord Blood Stem Cells Market Size by Country (2019-2024)
6.4 North America Cord Blood Stem Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cord Blood Stem Cells Market Size (2019-2030)
7.2 Europe Cord Blood Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cord Blood Stem Cells Market Size by Country (2019-2024)
7.4 Europe Cord Blood Stem Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cord Blood Stem Cells Market Size (2019-2030)
8.2 Asia-Pacific Cord Blood Stem Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cord Blood Stem Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Cord Blood Stem Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cord Blood Stem Cells Market Size (2019-2030)
9.2 Latin America Cord Blood Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cord Blood Stem Cells Market Size by Country (2019-2024)
9.4 Latin America Cord Blood Stem Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cord Blood Stem Cells Market Size (2019-2030)
10.2 Middle East & Africa Cord Blood Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cord Blood Stem Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Cord Blood Stem Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Cell Technology
11.1.1 Advanced Cell Technology Company Detail
11.1.2 Advanced Cell Technology Business Overview
11.1.3 Advanced Cell Technology Cord Blood Stem Cells Introduction
11.1.4 Advanced Cell Technology Revenue in Cord Blood Stem Cells Business (2019-2024)
11.1.5 Advanced Cell Technology Recent Development
11.2 California Stem Cell
11.2.1 California Stem Cell Company Detail
11.2.2 California Stem Cell Business Overview
11.2.3 California Stem Cell Cord Blood Stem Cells Introduction
11.2.4 California Stem Cell Revenue in Cord Blood Stem Cells Business (2019-2024)
11.2.5 California Stem Cell Recent Development
11.3 Cytori Therapeutics
11.3.1 Cytori Therapeutics Company Detail
11.3.2 Cytori Therapeutics Business Overview
11.3.3 Cytori Therapeutics Cord Blood Stem Cells Introduction
11.3.4 Cytori Therapeutics Revenue in Cord Blood Stem Cells Business (2019-2024)
11.3.5 Cytori Therapeutics Recent Development
11.4 Mesoblast Limited
11.4.1 Mesoblast Limited Company Detail
11.4.2 Mesoblast Limited Business Overview
11.4.3 Mesoblast Limited Cord Blood Stem Cells Introduction
11.4.4 Mesoblast Limited Revenue in Cord Blood Stem Cells Business (2019-2024)
11.4.5 Mesoblast Limited Recent Development
11.5 Opexa Therapeutics Inc.
11.5.1 Opexa Therapeutics Inc. Company Detail
11.5.2 Opexa Therapeutics Inc. Business Overview
11.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Introduction
11.5.4 Opexa Therapeutics Inc. Revenue in Cord Blood Stem Cells Business (2019-2024)
11.5.5 Opexa Therapeutics Inc. Recent Development
11.6 Athersys Inc.
11.6.1 Athersys Inc. Company Detail
11.6.2 Athersys Inc. Business Overview
11.6.3 Athersys Inc. Cord Blood Stem Cells Introduction
11.6.4 Athersys Inc. Revenue in Cord Blood Stem Cells Business (2019-2024)
11.6.5 Athersys Inc. Recent Development
11.7 Geron Corporation
11.7.1 Geron Corporation Company Detail
11.7.2 Geron Corporation Business Overview
11.7.3 Geron Corporation Cord Blood Stem Cells Introduction
11.7.4 Geron Corporation Revenue in Cord Blood Stem Cells Business (2019-2024)
11.7.5 Geron Corporation Recent Development
11.8 Neostem Inc.
11.8.1 Neostem Inc. Company Detail
11.8.2 Neostem Inc. Business Overview
11.8.3 Neostem Inc. Cord Blood Stem Cells Introduction
11.8.4 Neostem Inc. Revenue in Cord Blood Stem Cells Business (2019-2024)
11.8.5 Neostem Inc. Recent Development
11.9 CBR Systems, Inc.
11.9.1 CBR Systems, Inc. Company Detail
11.9.2 CBR Systems, Inc. Business Overview
11.9.3 CBR Systems, Inc. Cord Blood Stem Cells Introduction
11.9.4 CBR Systems, Inc. Revenue in Cord Blood Stem Cells Business (2019-2024)
11.9.5 CBR Systems, Inc. Recent Development
11.10 Cordlife
11.10.1 Cordlife Company Detail
11.10.2 Cordlife Business Overview
11.10.3 Cordlife Cord Blood Stem Cells Introduction
11.10.4 Cordlife Revenue in Cord Blood Stem Cells Business (2019-2024)
11.10.5 Cordlife Recent Development
11.11 Cryo-Cell
11.11.1 Cryo-Cell Company Detail
11.11.2 Cryo-Cell Business Overview
11.11.3 Cryo-Cell Cord Blood Stem Cells Introduction
11.11.4 Cryo-Cell Revenue in Cord Blood Stem Cells Business (2019-2024)
11.11.5 Cryo-Cell Recent Development
11.12 Cryo-Save AG (A Group of Esperite)
11.12.1 Cryo-Save AG (A Group of Esperite) Company Detail
11.12.2 Cryo-Save AG (A Group of Esperite) Business Overview
11.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Introduction
11.12.4 Cryo-Save AG (A Group of Esperite) Revenue in Cord Blood Stem Cells Business (2019-2024)
11.12.5 Cryo-Save AG (A Group of Esperite) Recent Development
11.13 Lifecell
11.13.1 Lifecell Company Detail
11.13.2 Lifecell Business Overview
11.13.3 Lifecell Cord Blood Stem Cells Introduction
11.13.4 Lifecell Revenue in Cord Blood Stem Cells Business (2019-2024)
11.13.5 Lifecell Recent Development
11.14 Stemcyte
11.14.1 Stemcyte Company Detail
11.14.2 Stemcyte Business Overview
11.14.3 Stemcyte Cord Blood Stem Cells Introduction
11.14.4 Stemcyte Revenue in Cord Blood Stem Cells Business (2019-2024)
11.14.5 Stemcyte Recent Development
11.15 Viacord
11.15.1 Viacord Company Detail
11.15.2 Viacord Business Overview
11.15.3 Viacord Cord Blood Stem Cells Introduction
11.15.4 Viacord Revenue in Cord Blood Stem Cells Business (2019-2024)
11.15.5 Viacord Recent Development
11.16 Smart Cells International Ltd.
11.16.1 Smart Cells International Ltd. Company Detail
11.16.2 Smart Cells International Ltd. Business Overview
11.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Introduction
11.16.4 Smart Cells International Ltd. Revenue in Cord Blood Stem Cells Business (2019-2024)
11.16.5 Smart Cells International Ltd. Recent Development
11.17 Cryoviva India
11.17.1 Cryoviva India Company Detail
11.17.2 Cryoviva India Business Overview
11.17.3 Cryoviva India Cord Blood Stem Cells Introduction
11.17.4 Cryoviva India Revenue in Cord Blood Stem Cells Business (2019-2024)
11.17.5 Cryoviva India Recent Development
11.18 Cordvida
11.18.1 Cordvida Company Detail
11.18.2 Cordvida Business Overview
11.18.3 Cordvida Cord Blood Stem Cells Introduction
11.18.4 Cordvida Revenue in Cord Blood Stem Cells Business (2019-2024)
11.18.5 Cordvida Recent Development
11.19 China Cord Blood Corporation
11.19.1 China Cord Blood Corporation Company Detail
11.19.2 China Cord Blood Corporation Business Overview
11.19.3 China Cord Blood Corporation Cord Blood Stem Cells Introduction
11.19.4 China Cord Blood Corporation Revenue in Cord Blood Stem Cells Business (2019-2024)
11.19.5 China Cord Blood Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
